REDEFINE 1 试验中 CagriSema 平均剂量与体重减轻之间的关系.pdf

1、Garvey WT et al.Presented at the 33rdEuropean Congress on Obesity(ECO),1215 May 2026,Istanbul,Trkiye.Relationship between mean CagriSema dose and weight loss in the REDEFINE 1 trialW.Timothy Garvey1,Jaime Almandoz2,Mikkel Hovden Christensen3,Cynthia Karenina Osorto Contreras3,Anthony N.Fabricatore4,

2、Thomas Bo Jensen3,Michael G.Knight5,Kirsi H.Pietilinen6,7,Carel W.le Roux8,91Department of Nutrition Sciences,University of Alabama at Birmingham,Birmingham,AL,USA;2Department of Internal Medicine,University of Texas Southwestern Medical Center,Dallas,Texas,USA;3Novo Nordisk A/S,Sborg,Denmark;4Novo

3、Nordisk Inc.,Plainsboro,NJ,USA;5The George Washington University,Washington,DC,USA;6Obesity Research Unit,Research Program for Clinical and Molecular Metabolism,Faculty of Medicine,University of Helsinki,Helsinki,Finland;7Healthy Weight Hub,Abdominal Center,Helsinki University Hospital and Universit

4、y of Helsinki,Helsinki,Finland;8Diabetes Complications Research Centre,University College Dublin,Dublin,Ireland;9Diabetes Research Centre,Ulster University,Belfast,UKThis study was sponsored by Novo Nordisk A/S and is registered with ClinicalTrials.gov(NCT05567796).Medical writing support was provid

5、ed by James Parkinson,PhD,CMPP,of Apollo,OPEN Health Communications,and funded by Novo Nordisk A/S,in accordance with Good Publication Practice(GPP)guidelines(ismpp.org/gpp-2022)Previously presented at the 43rd Annual Meeting of The Obesity Society held at ObesityWeek,47 November 2025,Atlanta,GA,USA

6、Scan QR code or visit the website below for:Science Hub linkshttps:/ WT et al.Presented at the 33rd European Congress on Obesity(ECO),1215 May 2026,Istanbul,Trkiye.Presenter disclosure W.Timothy Garvey reports the following:Receiving consulting fees for advisory boards for Boehringer Ingelheim,Eli L